Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis.

Jabbour, Elias J; Sasaki, Koji; Ravandi, Farhad; Short, Nicholas J; Garcia-Manero, Guillermo; Daver, Naval; Kadia, Tapan; Konopleva, Marina; Jain, Nitin; Cortes, Jorge; Issa, Ghayas C; Jacob, Jovitta; Kwari, Monica; Thompson, Philip; Garris, Rebecca; Pemmaraju, Naveen; Yilmaz, Musa; O'Brien, Susan M; Kantarjian, Hagop M.
Cancer; 125(15): 2579-2586, 2019 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-30985931